Successful Use of Posaconazole to Treat Invasive Cutaneous Fungal Infection in a Liver Transplant Patient on Sirolimus by Randah Dahlan, Ameen Patel, Shariq Haider

“…Fungi are an important and common cause of cutaneous infections affecting solid organ transplant recipients. These infections can represent a primary site of infection with the potential for dissemination, or a manifestation of metastatic infection. …”
Get full text

Dual bombard by Cytomegalovirus and Mycobacterium tuberculosis in a renal transplantee by Cinthujah Balachander, Indira Ananthapadmanabasamy, Ramasubramanian Viswanathan, Poongodi Santhanakumarasamy

“…In the first year following an organ transplant, more than 80% of patients encounter a minimum of one occurrence of infection. …”
Get full text

Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient by Kelly E. Schoeppler, Martin R. Zamora, Noelle M. Northcutt, Gerard R. Barber, Gayle O’Malley-Schroeder, Dennis M. Lyu

“…Because of the high incidence of morbidity and mortality associated with invasive fungal infections, antifungal prophylaxis is often used in solid organ transplant recipients. However, this prophylaxis is not universally effective and may contribute to the selection of emerging, resistant pathogens. …”
Get full text

Techniques for Melon Grafting by Wenjing Guan, Xin Zhao

“…Cost, along with the desire to customize scion cultivars and the need to produce organic transplants, has led many small and organic growers to choose to graft plants by themselves. …”
Get full text

The Public Health Service “Increased Risk” 2020 Policy Change Has not Improved Organ Utilization in the United States: A Nationwide Cohort Study by Dane C. Paneitz, MD, MPH, Stanley B. Wolfe, MD, MPH, Duc Giao, BA, Shannon N. Tessier, PhD, Leigh Anne Dageforde, MD, MPH, Nahel Elias, MD, Seyed Alireza Rabi, MD, PHD, Eriberto Michel, MD, David A. D’Alessandro, MD, Asishana A. Osho, MD, MPH

“…The organ utilization rate for each donor was determined by dividing the number of organs transplanted by the total number of organs available for procurement. …”
Get full text

Techniques for Melon Grafting by Wenjing Guan, Xin Zhao

“…Cost, along with the desire to customize scion cultivars and the need to produce organic transplants, has led many small and organic growers to choose to graft plants by themselves. …”
Get full text

Yield of Screening Colonoscopy in Renal Transplant Candidates by Turki AlAmeel, Bahaa Bseiso, Meteb M AlBugami, Sami AlMomen, Lee Stuart Roth

Get full text

A 36-Year-Old Renal Transplant Recipient Female with Leg Ulcer: A Case Report and Brief Review by Ali Monfared, Eftekhari Hojat, Seyed Alireza Mesbah, Abbas Darjani, Seyyede Zeinab Azimi

“…Opportunistic infections are common in organ transplant recipients. After 6 months of transplantation, patients have the highest risk of opportunistic infections such as cryptococcosis. …”
Get full text

Successfully Treated Norovirus- and Sapovirus-Associated Diarrhea in Three Renal Transplant Patients by Noha Ghusson, Gustavo Vasquez

“…Infectious diarrhea remains an underestimated yet significant cause of morbidity in solid organ transplant patients. Norovirus and sapovirus are often responsible for this presentation. …”
Get full text

Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate by Maya C. Graves, Sapna A. Mehta, Bonnie E. Lonze, Nicole M. Ali

“…The COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify transplant candidates with possible exposure to or history of COVID-19 infection, (2) outline a clinical and laboratory assessment to determine adequate clinical recovery from COVID-19 for transplantation, and (3) determine whether the possibility of perioperative COVID-19 transmission from the patient to staff would pose unacceptable risk. …”
Get full text

Comparison of time-to-event machine learning models in predicting biliary complication and mortality rate in liver transplant patients by Aref Andishgar, Sina Bazmi, Kamran B. Lankarani, Seyed Alireza Taghavi, Mohammad Hadi Imanieh, Gholamreza Sivandzadeh, Samira Saeian, Nazanin Dadashpour, Alireza Shamsaeefar, Mahdi Ravankhah, Hamed Nikoupour Deylami, Reza Tabrizi, Mohammad Hossein Imanieh

Get full text

Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults by Eric J Bow, Gerald Evans, Jeff Fuller, Michel Laverdière, Coleman Rotstein, Robert Rennie, Stephen D Shafran, Don Sheppard, Sylvie Carle, Peter Phillips, Donald C Vinh

“…Over the past few years, a new and broader understanding of the epidemiology and pathogenesis of C/IC has emerged and has been coupled with the availability of new antifungal agents and defined strategies for targeting groups at risk including, but not limited to, acute leukemia patients, hematopoietic stem cell transplants and solid organ transplants, and critical care unit patients. Accordingly, these guidelines have focused on patients at risk for C/IC, and on approaches of prevention, early therapy for suspected but unproven infection, and targeted therapy for probable and proven infection.…”
Get full text

High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana by Naomi Hauser, Tanmay Sahai, Rocco Richards, Todd Roberts

“…The drug is commonly used to prevent graft rejection in solid organ transplant and graft-versus-host disease in hematopoietic stem cell transplant patients. …”
Get full text

Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’ by Angela C Cheung, Aldo Montano-Loza, Mark Swain, Catherine Vincent, Eberhard Renner, Morris Sherman, Harry LA Janssen, Andrew L Mason

Get full text

Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas by Laura Eibenschutz, Delia Colombo, Caterina Catricalà

“…Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been shown to have antineoplastic activity in addition to its use as an immunosuppressive agent for the prevention of organ transplant rejection. We report the use of everolimus for the compassionate treatment of four elderly, nontransplant patients presenting with multiple basal cell carcinomas (BCC). …”
Get full text

Gastric Mucormycosis in a Renal Transplant Patient Treated with Isavuconazole Monotherapy by Imran Gani, Atbin Doroodchi, Kristina Falkenstrom, Holly Berry, Won Lee, Laura Mulloy, Muhammad Saeed, Rajan Kapoor

“…Gastrointestinal mucormycosis is a rare infection in solid organ transplant recipients. Our patient, a 79-year-old male, presented with severe dysphagia and odynophagia about 2 weeks after receiving a renal transplant. …”
Get full text

Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants by Emily E. Miller, Leigh Christopher Reardon

“…Although NE does not typically affect solid organ transplant patients, this patient had a variety of risk factors that may have predisposed her to development of NE such as severe neutropenia, supratherapeutic tacrolimus level, immunosuppression with cytotoxic agents, and elevated Epstein-Barr viral load. …”
Get full text

Interferon-gamma rescues dendritic cell calcineurin-dependent responses to Aspergillus fumigatus via Stat3 to Stat1 switching by Amit Adlakha, Thomas J. Williams, Xinxin Shou, Anna K. Reed, Boris Lenhard, Darius Armstrong-James

“…These findings provide key insight into the mechanisms of immunotherapy in organ transplant recipients with invasive fungal diseases.…”
Get full text

Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature by Toufik Mahfood Haddad, Mahesh Anantha Narayanan, Krista E. Shaw, Renuga Vivekanandan

“…Invasive fungal infections are very common in solid organ transplants and occur most frequently in the first three months after transplant. …”
Get full text

Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation by Yasutaka Tajima, Mariko Matsumura, Hiroaki Yaguchi, Yasunori Mito

“…In rare instances, recipients of organ transplants from human T-lymphotropic virus type I- (HTLV-I-) positive donors reportedly developed neurologic symptoms due to HTLV-I-associated myelopathy (HAM). …”
Get full text